Published by Iain Gilbert on 24th April 2024
(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.
URL: http://www.digitallook.com/dl/news/story/34243266/...